Gilda Marie Thomas
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Gilda Marie Thomas
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
25
| Subsidiary | Pharmaceuticals: Major | 25 |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Gilda Marie Thomas
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | President Chief Administrative Officer Director/Board Member Chief Executive Officer Director/Board Member Director of Finance/CFO Corporate Officer/Principal Compliance Officer Chief Tech/Sci/R&D Officer | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Administrative Officer Human Resources Officer Chief Executive Officer Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Sales & Marketing Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Director/Board Member President Sales & Marketing | |
| NEUROBO PHARMACEUTICALS, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Corporate Officer/Principal | |
| University of Virginia | College/University | Doctorate Degree Corporate Officer/Principal | |
| University of Michigan | College/University | Corporate Officer/Principal Masters Business Admin | |
| Temple University (Pennsylvania) | College/University | Corporate Officer/Principal Graduate Degree | |
| Glaxo, Inc. | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | ||
| LIQUIDIA CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Meryx, Inc.
 Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Envisia Therapeutics, Inc.
 Envisia Therapeutics, Inc. BiotechnologyHealth Technology Envisia Therapeutics, Inc. develops novel ocular therapies. It provides glaucoma drug therapies that include PRINT particle therapeutics to overcome biologic and chemical. The company was founded by 2013 is headquartered in Morrisville, NC. | Biotechnology | Director/Board Member Founder | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Liquidia Technologies, Inc.
 Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| NEUROLOGIX, INC. | Internet Software/Services | President Chief Executive Officer | |
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Compliance Officer | |
EffRx Pharmaceuticals SA
 EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology EffRx Pharmaceuticals SA manufactures and distributes specialty pharmaceutical products. The firm's focus areas include metabolic bone disease, oncology supportive care, pediatric medication, and medical support to companies in life cycle management. It also engages in licensing agreements and distribution and commercialization partnerships. The company was founded by Christer Ros?n in 1998 and is headquartered in Freienbach, Switzerland. | Pharmaceuticals: Other | Director/Board Member | |
Stockholm Chamber of Commerce
 Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Miscellaneous Commercial Services | Director/Board Member | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Director/Board Member | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Private Equity Investor | |
| University of Uppsala | College/University | Doctorate Degree | |
Premier Research Group Ltd.
 Premier Research Group Ltd. Miscellaneous Commercial ServicesCommercial Services Premier Research Group Ltd. provides contract research services to pharmaceutical industry. It engages in analgesics, neuroscience, medical devices, rare diseases and pediatrics. The company offers pediatric experience with both familiar and extremely rare childhood illnesses, including work at PICUs, NICUs, clinics, ERs and neonatal studies. Premier Research Group was founded in 2002 and is headquartered in Wokingham, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| The Royal Bachelors' Club | Corporate Officer/Principal | ||
| Swedish Academy For Pharmaceutical Sciences | Corporate Officer/Principal | ||
| Astra Hässle AB | Chief Executive Officer | ||
| EGETIS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | President | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Director/Board Member | |
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler. | Pharmaceuticals: Major | Chief Executive Officer | |
NC Life Sciences Organization
 NC Life Sciences Organization Miscellaneous Commercial ServicesCommercial Services North Carolina Biosciences Organization is non-profit organization, which focuses on legislative monitoring and lobbying activities at the state and federal level. The company was founded in 1994 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chairman | |
| Ortho-mcneil Neurologics, Inc. | President | ||
Farma Investment AS
 Farma Investment AS Real Estate Investment TrustsFinance Farma Investment AS invests in shares and real properties. The company was founded on June 23, 2011 and is headquartered in Oslo, Norway. | Real Estate Investment Trusts | Chairman | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member | |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Chairman | |
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
| Nicklasson Life Science AB | Corporate Officer/Principal | ||
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
| University of Missouri-Kansas City | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 27 |
| Schweden | 13 |
| Vereinigtes Königreich | 4 |
| Kanada | 3 |
| Schweiz | 3 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Finance | 3 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 112 |
| Corporate Officer/Principal | 80 |
| Independent Dir/Board Member | 37 |
| President | 34 |
| Chief Executive Officer | 26 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Seth A. Rudnick | 36 |
| Alf Gunnar Martin Nicklasson | 31 |
| Nancy Wysenski | 20 |
| Adrian Adams | 19 |
| James Tursi | 17 |
| Neal Fowler | 17 |
| Andrew Koven | 16 |
| Edward Myles | 16 |
| Mark Glickman | 14 |
| Jennifer Lou Armstrong-Owen | 14 |
| Elizabeth Cermak | 13 |
| Bruce A. Tomason | 12 |
| Jacques F. Réjeange | 10 |
| Drusilla Scott | 10 |
| Paul J. Rizzo | 10 |
- Börse
- Insiders
- Gilda Marie Thomas
- Unternehmensverbindungen